Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104126
Filing Date
2025-08-06
Accepted
2025-08-06 16:27:03
Documents
85
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20250630.htm   iXBRL 10-Q 3591053
2 EX-31.1 inva-ex31_1.htm EX-31.1 14431
3 EX-31.2 inva-ex31_2.htm EX-31.2 14432
4 EX-32 inva-ex32.htm EX-32 22868
  Complete submission text file 0000950170-25-104126.txt   15578322

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inva-20250630.xsd EX-101.SCH 1890382
88 EXTRACTED XBRL INSTANCE DOCUMENT inva-20250630_htm.xml XML 3531035
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 251190070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)